## Background: Frey syndrome was first described by baillarger in 1853. frey provided a detailed analysis and description as "auriculotemporal syndrome" in 1923. according to the literature, even the most recent therapeutic measures described for the treatment of patients with frey syndrome have li
Novel treatment of first bite syndrome using botulinum toxin type A
β Scribed by Byung-Joo Lee; Jin-Choon Lee; Young-Ok Lee; Soo-Geun Wang; Hak-Jin Kim
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 105 KB
- Volume
- 31
- Category
- Article
- ISSN
- 1043-3074
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Background
First bite syndrome is the development of pain in the parotid region after the first bite of each meal and can be seen after surgery of the parapharyngeal space. The purpose of this study is to evaluate the efficacy of intraglandular injection of botulinum toxin type A (BTA) in patients with first bite syndrome.
Methods
Five patients with first bite syndrome developed after head and neck surgery were treated by injection of BTA into parotid gland. All patients completed a 4βitem qualityβofβlife survey with a 10βpoint response scale designed to measure outcome of intraglandular injection of BTA.
Results
The first bite syndrome without or with sialogogue and degree of interference with daily activity with or without eating or drinking improved significantly at 1 and 3 month after injection (p < .05).
Conclusion
The BTA injection into affected parotid gland produces a decrease in the severity of first bite syndrome and improves the patient's quality of life. Β© 2009 Wiley Periodicals, Inc. Head Neck, 2009
π SIMILAR VOLUMES
## Background: Gustatory sweating is a common complication of parotid surgery. injection of botulinum toxin a has been reported as a safe and effective treatment option for patients with frey's syndrome. ## Patients and methods: A total of 69 patients who had undergone superficial parotidectomy b
## Abstract Fifteen patients with torticollis who had been treated with repeated injections of botulinum toxin type A (botox A) developed antibodies to the toxin. This resulted in loss of benefit in the 13 patients who had improved with botox A injections and failure to develop muscle atrophy after
## Abstract ## Background. Neck dissection surgery is often followed by chronic head and neck pain. To date optimal treatment of this type of pain is lacking. Botulinum toxin type A (BTXβA) has been shown to be effective in the treatment of myofascial pain syndrome and headache. In a pilot study,